• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Stroke in Older Adults Living in Care Homes: Results From a National Data Linkage Study in Wales
To determine the proportion of older people moving to care homes with a recent stroke, incidence of stroke after moving to a care home, mortality following stroke, and secondary stroke prevention management in older care home residents.
Source: Journal of the American Medical Directors Association - June 3, 2022 Category: Health Management Authors: Stephanie L. Harrison, Gregory Y.H. Lip, Ashley Akbari, Fatemeh Torabi, Leona A. Ritchie, Asangaedem Akpan, Julian Halcox, Sarah Rodgers, Joe Hollinghurst, Daniel Harris, Deirdre A. Lane Tags: Original Study Source Type: research

Post-acute organisational audit report
Sentinel Stroke National Audit Programme (SSNAP) - Based on data from 664 post-acute services, this report describes the organisation of post-acute stroke care in England, Wales, Northern Ireland, the Isle of Man and Jersey as of 1 April 2021. Overall, the report found some improvements when compared to 2015, including the fact that 99 per cent of services have access to an occupational therapist, physiotherapist and rehab assistant (95 per cent in 2015).ReportMore detail
Source: The Kings Fund - Health Management Specialist Collection - December 13, 2021 Category: Health Management Authors: The King ' s Fund Library Tags: NHS performance and productivity Source Type: news

Inclusion of a care bundle for fever, hyperglycaemia and swallow management in a National Audit for acute stroke: evidence of upscale and spread
In the Quality in Acute Stroke Care (QASC) trial undertaken in stroke units (SUs) located in New South Wales (NSW), Australia (2005 –2010), facilitated implementation of a nurse-led care bundle to manage fever,...
Source: Implementation Science - September 2, 2019 Category: Health Management Authors: Tara Purvis, Sandy Middleton, Louise E. Craig, Monique F. Kilkenny, Simeon Dale, Kelvin Hill, Catherine D ’Este and Dominique A. Cadilhac Tags: Research Source Type: research

Ticagrelor for Secondary Prevention of Atherothrombotic Events After Myocardial Infarction: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
AbstractThe National Institute for Health and Care Excellence (NICE) invited AstraZeneca, the manufacturer of ticagrelor (Brilique®), to submit evidence on the clinical and cost effectiveness of ticagrelor 60  mg twice daily (BID) in combination with low-dose aspirin [acetylsalicylic acid (ASA)] compared with ASA only for secondary prevention of atherothrombotic events in patients with a history of myocardial infarction (MI) and who are at increased risk of atherothrombotic events. Kleijnen Systematic R eviews Ltd (KSR), in collaboration with Maastricht University Medical Centre+, was commissioned as the evidence review ...
Source: PharmacoEconomics - January 18, 2018 Category: Health Management Source Type: research